# Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder

> **NCT01337609** · PHASE4 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 5 (actual)

## Conditions studied

- Major Depressive Disorder
- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Ganeden BC30
- **OTHER:** Placebo (sugar pill)
- **OTHER:** Ganeden BC30, Placebo (sugar pill)

## Key facts

- **NCT ID:** NCT01337609
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Because the study sponsor chose to discontinue funding for this protocol following a change in leadership, the study was terminated early.
- **Last updated:** 2013-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337609, "Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01337609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*